Pharma giant Pfizer (US.PFE) acquires Durham drugmaker for $525M - 08 aprilie 2022

A global pharmaceutical giant is acquiring a drugmaker with a headquarters in Durham for up to $525 million. Pfizer announced Thursday it has reached a deal to acquire ReViral, a clinical stage biopharmaceutical company that's developing therapeutics for respiratory syncytial virus (RSV), and its pipeline of drug candidates. The deal includes upfront payments and development milestones.